Cartesian Therapeutics (RNAC) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.38
-0.75
-0.13
0.5

Details

Expected EPS
-0.847067
Actual EPS
-1.38
Surprise EPS
-0.53
Surprise Percent
-62.92%

Description

⁨Cartesian Therapeutics⁩ (⁦RNAC⁩) has reported earnings of ⁦-1.38⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts